Potent and selective human β3-adrenergic receptor antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 2, 1999, Pages 649-655

  Candelore, Mari Rios ^a   Deng, Liping ^a   Tota, Laurie ^a   Guan, Xiao Ming ^a   Amend, Angela ^a   Liu, Yong ^a   Newbold, Ron ^a   Cascieri, Margaret A ^a   Weber, Ann E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID METHYL ESTER; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BENZENESULFONAMIDE DERIVATIVE; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRANOLOL; CARVEDILOL; CYCLIC AMP; GLYCEROL; IODINE 125; ISOPRENALINE; L 748328; L 748337; METOPROLOL; N [4 [2 [[3 (4 HYDROXYPHENOXY) 2 HYDROXYPROPYL]AMINO]ETHYL]PHENYL] 4 IODOBENZENESULFONAMIDE; N [4 [2 [[3 [3 (ACETAMIDOMETHYL)PHENOXY] 2 HYDROXYPROPYL]AMINO]ETHYL]PHENYL]BENZENESULFONAMIDE; N [4 [2 [[3 [3 (AMINOSULFONYL)PHENOXY] 2 HYDROXYPROPYL] AMINO]ETHYL]PHENYL]BENZENESULFONAMIDE; NADOLOL; PROPANOLAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; DRUG RESEARCH; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADIPOCYTES; ADRENERGIC BETA-ANTAGONISTS; AMINOPHENOLS; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CYCLIC AMP; HUMANS; LIGANDS; LIPOLYSIS; MACACA MULATTA; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 0032765261     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arch JRS, Ashworth AT, Cawthorne MA, Pacey V, Sennitt MV, Thody VE, Wilson C and Wilson S (1984) Atypical β-adrenoceptor on brown adipocytes: Target for anti-obesity drugs. Nature (Lond) 309:163-165.
2. 3- and atypical β-adrenoceptors. Med Res Rev 13:663-729.
3. 3-Adrenoceptor in guinea pig brown and white adipocytes: Low expression and lack of function. Am J Physiol 271:R1729-R1738.
4. 3-adrenergic receptor. Mol Pharmacol 44:1094-1104.
5. 3-adrenergic receptor mutant. Endocrinology 137:2638-2641.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. 3-adrenoceptor antagonist SR 59,230A. Br J Pharmacol 117:1374-1376.
8. 3-adrenergic receptor. Science 245:1118-1121.
9. 3-adrenergic receptor in 3T3-F442A adipocytes. J Biol Chem 270:10952-10959.
10. 3-adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest 101:2387-2393.
11. 3-adrenergic receptor. J Pharmacol Exp Ther 287:720-724.
12. 4-adrenoceptor. Br J Pharmacol 122:1244-1250.
13. 3-adrenergic receptor messenger ribonucleic-acids. Endocrinology 136:1025-1031.
14. Harms HH, Zaagsma J and Van Del Wal B, Arch JRS, Chapman H, Smith SA, Poyser RH and Ruffolo RR (1998) Affinity of carvedilol for recombinant human adrenoceptors. Pharmacol Rev Commun 10:43-50.
15. Holloway BR, Howe R, Rao BS, Stribling D, Mayers RM, Briscoe MG and Jackson JM (1991) ICI D7114, a novel selective β-adrenoceptor agonist selectively stimulates brown fat and increases whole-body oxygen consumption. Br J Pharmacol 104:97-107.
16. 3-adrenoceptor knockout mice. Mol Pharmacol 53:670-675.
17. 4-adrenergic receptor mRNA in man. J Clin Invest 91:344-349.
18. Lands AM, Arnold A, MacAuliff JP and Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature (Lond) 214:597-598.
19. 3-adrenergic receptor isoforms expressed in the CHO cell. Gastroenterol Clin Biol 19:668-672.
20. 3) β-adrenoceptors. Pharmacol Commun 6:253-258.
21. 3-selective antagonists, aryloxvpropanolaminotetralins. Br J Pharmacol 117:1374-1376.
22. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG and Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (Lond) 393:333-339.
23. 3-adrenoceptor agonist. Eur J Pharmacol 291:359-366.
24. Möhler H and Fritschy JM (1999) GABAB receptors make it to the top - as dimers. Trends Pharmacol Sci 20:87-89.
25. 3-adrenergic receptor antagonist SR 59.230A. Mol Pharmacol 49:7-14.
26. 3-adrenergic receptor. Bur J Biochem 230:350-358.
27. 3-adrenoceptor knockout mice: Evidence for a new β-adrenergic receptor in brown adipose tissue. Br J Pharmacol 124:1684-1688.
28. 4-adrenoceptor" in rat atrium. Br J Pharmacol 122:1244-1250.
29. Strader CD, Fong TM, Candelore MR, Castieri MA, Weinberg D and Bayne M (1995) Adrenergic receptors as models for the family of G protein-coupled receptors. Pharmacol Commun 6:195-202.
30. 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 37:421-450.
31. 3-adrenoceptors: Strosberg and Pietri-Rouxel reply. Trends Pharmacol Sci 18:52-53.
32. 3-adrenergic receptor gene. J Biol Chem 270:29483-29492.
33. Tota MR and Strader CD (1991) Characterization of the binding domain of the β-adrenergic receptor with the fluorescent antagonist carazolol. J Biol Chem 265:16891-16897.
34. 3-adrenergic receptor. Bioorg Med Chem Lett 8:1101-1106.
35. 3-adrenoceptor depends on receptor expression level and nature of assay. J Pharmacol Exp Ther 279:214-221.